Fibroids often shrink or disappear during menopause; however, women that experience severe fibroid symptoms often do not wish to wait to see if the fibroids relent. Once confirmed with an ultrasound and pelvic exam, the traditional approach to treating fibroids has been to perform a full or partial hysterectomy or the surgical removal of the fibroids. As uterine fibroids increase in size and age, the body develops new arteries and veins that supply blood to the masses, increasing the vascular network in the pelvis. A minimally invasive interventional procedure called a Uterine Fibroid Embolization (UFE) can eliminate fibroids by accessing this vascular network and shutting down the blood flow to the fibroids, causing them to skink and disappear. A UFE eliminates the need for major surgery, long recovery times, and the complications of having a hysterectomy.
Learn more about our treatment options.
Endovascular Today – Analysis Shows Similar Efficacy for UFE Versus Myomectomy, With Greater Improvement in Menorrhagia and Less Need for Blood Transfusion
March 25, 2019— Research presented at the Society of Interventional Radiology’s (SIR) Annual Scientific Meeting found that patients with uterine fibroids treated via embolization (UFE) were less likely to require blood transfusions than those treated with surgical myomectomy and that similar efficacy could be expected between the procedures.